Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Minarik J, Radocha J, Jungova A, Straub J, Jelinek T, Pika T, Pour L, Pavlicek P, Harvanova L, Pospisilova L, Krhovska P, Novakova D, Jindra P, Spicka I, Plonkova H, Stork M, Bacovsky J, Maisnar V, Hajek R. Minarik J, et al. Among authors: jungova a. Cancers (Basel). 2022 Oct 21;14(20):5165. doi: 10.3390/cancers14205165. Cancers (Basel). 2022. PMID: 36291949 Free PMC article.
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry Data.
Maisnar V, Pour L, Spicka I, Jelinek T, Minarik J, Jungova A, Stork M, Straub J, Radocha J, Pika T, Pospisilova L, Nair S, Kunovszki P, Hajek R. Maisnar V, et al. Among authors: jungova a. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):145-153. doi: 10.1016/j.clml.2022.11.001. Epub 2022 Nov 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36567210
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
Stork M, Sevcikova S, Jelinek T, Minarik J, Radocha J, Pika T, Pospisilova L, Spicka I, Straub J, Pavlicek P, Jungova A, Knechtova Z, Sandecka V, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: jungova a. Biomedicines. 2022 Oct 11;10(10):2535. doi: 10.3390/biomedicines10102535. Biomedicines. 2022. PMID: 36289797 Free PMC article.
Changes of cytokine levels during granulocyte-colony-stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance.
Lysák D, Hrabětová M, Vrzalová J, Koza V, Navrátilová J, Svoboda T, Jungová A, Topolčan O. Lysák D, et al. Among authors: jungova a. Transfusion. 2011 Feb;51(2):319-27. doi: 10.1111/j.1537-2995.2010.02863.x. Epub 2010 Aug 30. Transfusion. 2011. PMID: 20804529
Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.
Vokurka S, Koza V, Jungova A, Navratilova J, Svoboda T, Jindra P, Steinerova K, Vyrutova R. Vokurka S, et al. Among authors: jungova a. Bone Marrow Transplant. 2012 Jun;47(6):867-8. doi: 10.1038/bmt.2011.173. Epub 2011 Aug 29. Bone Marrow Transplant. 2012. PMID: 21874056 No abstract available.
[The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation].
Vokurka S, Koza V, Jungová A, Navrátilová J, Svoboda T, Jindra P, Steinerová K, Hrabětová M, Výrutová R, Novák L. Vokurka S, et al. Among authors: jungova a. Klin Onkol. 2012;25(1):42-6. Klin Onkol. 2012. PMID: 22348219 Czech.
45 results